In this senior International CLS leadership role, you will help shape the global launch strategy for a transformative treatment for blood cancers, driving impact across diverse markets and healthcare systems. Executive Director, Haematology, International Commercial Launch Strategy
Location: Basel, Switzerland In this senior International CLS leadership role, you will help shape the global launch strategy for a transformative treatment in one of two blood disorders; chronic myelogenous leukemia (CML) or myelofibrosis (MF), driving impact across diverse markets and healthcare systems. You will combine scientific insight, commercial expertise, and cross‑functional partnership to support timely market entry and sustainable growth. Working closely with international and country teams, you will guide strategic decision‑making, integrate market and customer insights, and encourage innovative approaches that expand patient access and strengthen leadership in haematology. This is an opportunity to influence the journey from development to commercialisation while enabling teams across regions to make a meaningful difference for people living with serious blood cancers. Key Responsibilities
Shape the international launch strategy for a leading CML or MF treatment, ensuring alignment with haematology priorities and patient needs. Coordinate cross‑functional collaboration across medical, regulatory, access, commercial, and supply teams to support effective execution. Enable launch readiness across priority markets by identifying risks early and supporting practical mitigation plans. Use market insights, competitive intelligence, and stakeholder feedback to refine global positioning and messaging. Partner with regional and country teams to support local execution while maintaining alignment with global strategy. Define, monitor, and govern critical launch milestones and performance indicators to support timely, evidence‑based decisions. Communicate clearly with senior leaders on vision, progress, and strategic priorities across international markets. Promote strong standards of compliance, operational excellence, and best practice in launch execution. Contribute to development planning by helping shape target product profiles and evidence needs that support market access potential. Lead commercial excellence initiatives and strengthen customer‑centred engagement approaches across regions. Essential Requirements
Recent, significant Profit and Loss (P&L) leadership experience at country level. Approximately 15 years of progressive commercial experience across country and above‑country roles. Proven success leading launches and shaping therapeutic area strategy across diverse international markets. Strong understanding of hematology or related specialty areas, with experience translating scientific insights into strategic plans. Demonstrated ability to lead in complex, fast‑evolving environments and deliver results across high‑growth markets. Expertise in turning scientific data into differentiated value propositions across pre‑launch and lifecycle management phases. Consistent record of influencing cross‑unit and cross‑functional teams to achieve shared strategic goals. Ability to integrate multiple market insights and stakeholder perspectives to guide clear, evidence‑based decision‑making. Desirable Requirements
Proven ability to lead and inspire diverse, cross‑regional teams, fostering collaboration, clarity, and strategic alignment across complex environments. Demonstrated strength in influencing senior stakeholders and navigating matrixed structures to drive shared priorities and long‑term business impact. Commitment to Diversity and Inclusion
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
#J-18808-Ljbffr
Location: Basel, Switzerland In this senior International CLS leadership role, you will help shape the global launch strategy for a transformative treatment in one of two blood disorders; chronic myelogenous leukemia (CML) or myelofibrosis (MF), driving impact across diverse markets and healthcare systems. You will combine scientific insight, commercial expertise, and cross‑functional partnership to support timely market entry and sustainable growth. Working closely with international and country teams, you will guide strategic decision‑making, integrate market and customer insights, and encourage innovative approaches that expand patient access and strengthen leadership in haematology. This is an opportunity to influence the journey from development to commercialisation while enabling teams across regions to make a meaningful difference for people living with serious blood cancers. Key Responsibilities
Shape the international launch strategy for a leading CML or MF treatment, ensuring alignment with haematology priorities and patient needs. Coordinate cross‑functional collaboration across medical, regulatory, access, commercial, and supply teams to support effective execution. Enable launch readiness across priority markets by identifying risks early and supporting practical mitigation plans. Use market insights, competitive intelligence, and stakeholder feedback to refine global positioning and messaging. Partner with regional and country teams to support local execution while maintaining alignment with global strategy. Define, monitor, and govern critical launch milestones and performance indicators to support timely, evidence‑based decisions. Communicate clearly with senior leaders on vision, progress, and strategic priorities across international markets. Promote strong standards of compliance, operational excellence, and best practice in launch execution. Contribute to development planning by helping shape target product profiles and evidence needs that support market access potential. Lead commercial excellence initiatives and strengthen customer‑centred engagement approaches across regions. Essential Requirements
Recent, significant Profit and Loss (P&L) leadership experience at country level. Approximately 15 years of progressive commercial experience across country and above‑country roles. Proven success leading launches and shaping therapeutic area strategy across diverse international markets. Strong understanding of hematology or related specialty areas, with experience translating scientific insights into strategic plans. Demonstrated ability to lead in complex, fast‑evolving environments and deliver results across high‑growth markets. Expertise in turning scientific data into differentiated value propositions across pre‑launch and lifecycle management phases. Consistent record of influencing cross‑unit and cross‑functional teams to achieve shared strategic goals. Ability to integrate multiple market insights and stakeholder perspectives to guide clear, evidence‑based decision‑making. Desirable Requirements
Proven ability to lead and inspire diverse, cross‑regional teams, fostering collaboration, clarity, and strategic alignment across complex environments. Demonstrated strength in influencing senior stakeholders and navigating matrixed structures to drive shared priorities and long‑term business impact. Commitment to Diversity and Inclusion
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
#J-18808-Ljbffr
Executive Director, Haematology, International Commercial Launch Strategy Arbeitgeber: Novartis Farmacéutica
Novartis Farmacéutica ist ein hervorragender Arbeitgeber, der seinen Mitarbeitern in Basel, Schweiz, eine dynamische und unterstützende Arbeitsumgebung bietet. Mit einem starken Fokus auf Innovation und Zusammenarbeit fördert das Unternehmen die persönliche und berufliche Weiterentwicklung seiner Mitarbeiter durch umfassende Schulungsprogramme und spannende Projekte im Bereich Life Sciences und KI. Die attraktiven Vergütungen und umfangreichen Sozialleistungen machen Novartis zu einem idealen Ort für Fachkräfte, die einen bedeutenden Beitrag zur Gesundheitsversorgung leisten möchten.
